Centrum 7/6  banner

Prestige Brands CEO Mannelly to retire

Print Friendly, PDF & Email

TARRYTOWN, N.Y. — Matthew Mannelly is retiring as president and chief executive officer of Prestige Brands Holdings Inc. and will be succeeded by chief financial officer Ron Lombardi.

Prestige Brands said late Wednesday that Mannelly is slated to retire on June 1. With the move, he also will be retiring from the company’s board of directors. Lombardi will become president and CEO upon Mannelly’s retirement.

“It has been a privilege to partner with Ron during this important phase of the company’s history,” commented Mannelly, who has served as president and CEO of Prestige Brands and on its board since September 2009. “Ron has contributed to all aspects of the business, including development and execution of our three-pronged growth strategy, and I leave Prestige with tremendous confidence in the management team’s ability under Ron’s continued leadership. I know we are well-positioned with very strong momentum entering fiscal 2016, making now the appropriate time for me to retire and make this change for myself and my family.”

Lombardi joined Prestige as CFO in December 2010. His experience includes five years as CFO and chief operating officer for Cannondale Sports Group/Dorel Recreation and Leisure, a consumer sporting equipment and apparel company. He has also held leadership positions in finance at Gerber Scientific and at Emerson Electric.

“Ron’s strong leadership skills and breadth of experience have been among the important factors in our record growth,” stated Gary Costley, lead director on Prestige Brands’ board. “As part of our succession planning, the board of directors determined that Ron would be the ideal successor to Matt as the next president and chief executive officer of Prestige Brands, and we are pleased to have him leading the company through its next phase of growth.”

Prestige Brands markets and distributes brand-name over-the-counter health care and household cleaning products in the United States, Canada, Australia and other international markets. Its portfolio of brands includes Monistat®women’s health products, Nix lice treatments, Chloraseptic sore throat treatments, Clear Eyes eye care products, Compound W wart treatments, The Doctor’s NightGuard dental protector, Little Remedies and PediaCare pediatric medicines, Efferdent denture care products, Luden’s throat drops, Dramamine motion sickness treatments, BC and Goody’s headache remedies, Beano gas prevention, Debrox earwax remover and, in Canada, Gaviscon antacid.


ECRM_06-01-22


Comments are closed.

PP_1170x120_10-25-21